Tj. O'Brien et al., The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy, J NUCL MED, 42(8), 2001, pp. 1158-1165
Citations number
38
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
F-18-FDG PET is an accurate and reliable technique for localizing medically
refractory temporal lobe epilepsy, but widespread use has been hindered by
limited reimbursement in many countries because of the high cost of tradit
ional PET equipment and radioisotopes. Additionally, the place of FDG PET a
s a cost-effective tool for presurgical evaluation of epilepsy has been que
stioned because of limited data showing that FDG PET provides localization
information incremental to that provided by more established techniques, pa
rticularly MRI and ictal electroencephalography (EEG). Three-dimensional (3
D), large-field-of-view, sodium iodide crystal-based scanners have lower eq
uipment and running costs and better multiplanar resolution than traditiona
l 2-dimensional bismuth germanate (BGO) systems but have not yet been valid
ated for evaluation of epilepsy. Our purpose was to investigate the localiz
ation rate, accuracy, and prognostic value of FDG PET images acquired on a
3D, large-field-of-view, sodium iodide crystal-based PET scanner in the pre
surgical evaluation of intractable partial epilepsy. We also wanted to esta
blish the incremental value of FDG PET over established MRI and ictal EEG t
echniques. Methods: Fifty-five patients who were surgical candidates becaus
e of medically refractory partial epilepsy were examined. For most of these
patients, the lesions had not been clearly localized on conventional asses
sment. The FDG PET scans were reviewed independently by 2 reviewers who wer
e unaware of the patients' clinical details, ictal EEG findings, and volume
tric MRI results, and the FDG PET results were correlated with those of MRI
and EEG and with postsurgical outcome. Results: Forty-two patients (76%) h
ad localizing FDG PET images (37 temporal, 5 extratemporal). The ictal EEG
recordings were localizing in 66%, and the MRI findings were localizing in
27% (which increased to 35% after the MRI findings were reviewed again afte
r PET). Concordance between the site of the PET localizations and the site
of the MRI or EEG localizations was 100%. The PET images were localizing in
63% and 69% of patients with nonlocalizing ictal EEG and MRI findings, res
pectively. Twenty-one of 24 patients who subsequently underwent epilepsy su
rgery had localizing FDG PET images; of these 21 patients, 18 (86%) had a c
lass I outcome. Multiple regression analysis showed the FDG PET results to
be predictive of postsurgical outcome independently of the MRI findings. Co
nclusion: For intractable partial epilepsy, FDG PET using a 3D, large-field
-of-view, sodium iodide crystal-based scanner provided clinically useful lo
calizing information that was at least as accurate as the results reported
for traditional BGO-based scanners. The PET images provided prognostically
significant localization information incremental to that provided by volume
tric MRI and ictal EEG, particularly if 1 of these studies was nonlocalizin
g.